Cellebrite
CLBT
44 hedge funds and large institutions have $162M invested in Cellebrite in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 6
1.35% more ownership
Funds ownership: 20.31% → 21.66% (+1.3%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
4% less funds holding
Funds holding: 46 → 44 (-2)
18% less capital invested
Capital invested by funds: $196M → $162M (-$34.6M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
74% less call options, than puts
Call options by funds: $506K | Put options by funds: $1.98M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$6.99M |
| 2 |
CC
Crosslink Capital
Menlo Park,
California
|
+$3.42M |
| 3 |
GRIM
Greenhaven Road Investment Management
Greenwich,
Connecticut
|
+$2.02M |
| 4 |
SAM
Serengeti Asset Management
New York
|
+$627K |
| 5 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$232K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSCM
Light Street Capital Management
Palo Alto,
California
|
-$504K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$215K |
| 3 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
-$199K |
| 4 |
E
Ergoteles
New York
|
-$177K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$81.3K |
CLBT Hedge Fund Activity: Q3 2022 in Review
44 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Cellebrite (CLBT) for Q3 2022, worth a combined $162M — down 18% from $196M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CLBT and 4 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 18 added.
The largest buyer was Phoenix Financial, adding an estimated $6.99M. The largest seller was Light Street Capital Management, cutting an estimated $504K.
- 44 institutional investors held Cellebrite (CLBT) as of Q3 2022, down from 46 in Q2 2022.
- Funds reported $162M of Cellebrite stock for Q3 2022, down 18% quarter-over-quarter.
- 4 funds opened new Cellebrite positions in Q3 2022 and 6 closed out, a net change of -2 holders.
- The largest Cellebrite buyer in Q3 2022 was Phoenix Financial, an estimated $6.99M added.
- The largest Cellebrite seller in Q3 2022 was Light Street Capital Management, an estimated $504K sold.
Based on aggregated 13F filings for Q3 2022.